Bp/USP250ml 5% Glucose Injection

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: For external use
Still deciding? Get samples of US$ 100/Piece
Request Sample
Manufacturer/Factory, Trading Company
Gold Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Registered Capital
5000000 RMB
Plant Area
101~500 square meters
  • Bp/USP250ml 5% Glucose Injection
  • Bp/USP250ml 5% Glucose Injection
  • Bp/USP250ml 5% Glucose Injection
  • Bp/USP250ml 5% Glucose Injection
  • Bp/USP250ml 5% Glucose Injection
  • Bp/USP250ml 5% Glucose Injection
Find Similar Products
  • Overview
  • Product Description
  • Packaging & Shipping
  • Company Profile
Overview

Basic Info.

Suitable for
Elderly, Children, Adult
State
Liquid
Shape
Injection
Type
Organic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Certification
GMP Bp/USP
Shelf Life
3 Years
Transport Package
Carton
Specification
500ml*10/BOX
Trademark
voice-bio
Origin
China
HS Code
3004201700
Production Capacity
10000000

Product Description

Product Description

BP/USP 250ml 5% Glucose injection
Bp/USP250ml 5% Glucose Injection

The main ingredients and chemical name of this product are: glucose

Molecular formula: C6H12O6·H2O

Molecular weight: 198.17

Properties

This product is a colorless or almost colorless clear liquid; it has a sweet taste.

Pharmacology and Toxicology

Glucose is one of the main sources of calories in the human body. Every 1 gram of glucose can produce 4 calories (16.7KJ) of heat energy, so it is used to supplement calories and treat hypoglycemia. When glucose and insulin are intravenously infused together, potassium ions are needed for glycogen synthesis, so that potassium ions enter the cells and the blood potassium concentration drops, so it is used to treat hyperkalemia. Glucose is the main substance that maintains and regulates the osmotic pressure of peritoneal dialysate.

Pharmacokinetics

Intravenous glucose directly enters the blood circulation. Glucose is completely oxidized in the body to produce CO2 and water, which are excreted from the body through the lungs and kidneys, while generating energy, which can also be converted into glycogen and fat storage. Generally, the ability of a normal human body to utilize glucose per minute is 6 mg/Kg.

Indications

1. Supplement heat and body fluids, for inadequate eating or loss of a large amount of body fluids (such as vomiting, diarrhea, etc.), starvation ketosis caused by various reasons;

2. Hypoglycemia;

3. Hyperkalemia;

4. Prepare peritoneal dialysate;

Dosage

1. Supplementary heat energy: When the patient's eating is reduced or unable to eat due to some reasons, 10% glucose injection can be given intravenously, and body fluids can be supplemented at the same time. The amount of glucose is calculated based on the required heat energy.

2. Hypoglycemia: oral administration for mild cases. In severe cases, glucose injection can be used intravenously.

3. Starvation ketosis: oral administration for mild cases. In severe cases, intravenous infusion of glucose injection is used, and 100g of glucose per day can basically control the condition.

4. Water loss: intravenous drip of 5% glucose injection for isotonic water loss.

5. Hyperkalemia: 10% injection, plus 1 unit of regular insulin infusion for every 2~4g glucose, can reduce serum potassium concentration. However, this therapy only allows extracellular potassium ions to enter the cell, and the total potassium content in the body remains unchanged. If you do not take measures to excrete potassium, there is still the possibility of hyperkalemia again.

Adverse reactions

1. Phlebitis: occurs when hypertonic glucose injection is instilled. Switching to large intravenous drip, the incidence of phlebitis decreased.

2. Extravasation of high concentration solution injection can cause local swelling and pain.

3. Reactive hypoglycemia: combined with excessive use of insulin, the original tendency to hypoglycemia and the sudden stop of total intravenous nutrition therapy are likely to occur.

4. Hyperglycemia nonketotic coma: It is more common in diabetes, stress state, high-dose glucocorticoids, uremic peritoneal dialysis patients given intraperitoneal hypertonic glucose solution and total intravenous nutrition therapy.

5. Electrolyte disorders: Hypokalemia, hyponatremia and hypophosphatemia are prone to occur when simply supplementing glucose for a long time.

6. Those with original cardiac insufficiency.

Taboo

1. Those who have not controlled diabetic ketoacidosis;

2. Non-ketotic hypertonic state of hyperglycemia.

3. Glucose galactose malabsorption (avoid oral administration).

Precautions

1. Most gastrectomy patients are prone to dumping syndrome and hypoglycemia during oral glucose tolerance test, and should be changed to intravenous glucose test;

2. Patients with periodic paralysis and hypokalemia;

3. It is easy to induce hyperglycemia in stress state or application of glucocorticoid;

4. Edema, severe heart and kidney insufficiency, ascites due to liver cirrhosis are likely to cause water retention, and the amount of fluid infusion should be controlled; especially for those with cardiac insufficiency, the drip rate should be controlled.

[Medicine for pregnant and lactating women]

Injecting too much glucose during delivery can stimulate fetal insulin secretion and cause hypoglycemia in the baby after delivery.

Children's Medication

Too fast or too much fluid can cause palpitations, arrhythmia, and even acute left heart failure.

Medication for elderly patients

Too fast or too much fluid can cause palpitations, arrhythmia, and even acute left heart failure.

 

Shelf life:3years
Packaging & Shipping

Comercial Packing 10x10's/Box or Customized
Production Time About 30-60days after artwork confirmed
  

Packaging & Shipping

Bp/USP250ml 5% Glucose Injection

Company Profile

Since 2015, NINGBO VOICE BIOCHEMIC CO. LTD. is a professional company to offer one-package service for FPP (Finished Pharmaceutical Products ); APIs (Active Pharmaceutical Ingredients); Chemicals (Pharmaceutical Intermediates ); Veterinary Pharmaceuticals.that meet requirements of Standard GMP and current BP,USP version.
 

Bp/USP250ml 5% Glucose Injection
Bp/USP250ml 5% Glucose Injection
Bp/USP250ml 5% Glucose Injection

 

Bp/USP250ml 5% Glucose Injection
Bp/USP250ml 5% Glucose Injection
Bp/USP250ml 5% Glucose Injection

 



Certifications
Business License, Manufacturing License, Certificate of Pharmaceutical Products (CoPP), Free Sales Certificate (FSC), and technical documents for registration.

Our Service
1.Free professional and creative artwork design.
2.OEM service.
3.Registration documents supported.
4.Packing as your request, with photo before shipment.
 


We will spare no efforts to meet your demands!

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier